Since 1988, Derposa has been a major brand in the manufacturing and commercialization of special laminating films for graphic arts. Derposa became part of Taghleef Industries in 2014.
The company recently launched a new range of antimicrobial film which according to the company is effective against coronavirus SARS-CoV-2.
Trials have shown that after 24 hours there is a reduction of more than 84% of coronavirus SARS-CoV-2 on its surface area compared to a laminating film without the antimicrobial agent.
Derprosa Antimicrobial is the new designation of company’s Bacterstop film which has been widely considered one of the best films to prevent infection by bacteria. Now, the company is set out to verify its effectiveness for viruses by testing with different types of coronavirus. The film was first tested with the feline coronavirus due to availability and capabilities of independent specialized laboratories. Finally, the film was recently tested with the human coronavirus SARS-CoV-2. Deprosa claims in both trials, the performance of Deprosa Antimicrobial films has been outstanding.
Test results proved that Derprosa Antimicrobial inhibits proliferation and neutralizes the survival of bacteria and viruses on non-porous surfaces. It has been specifically tested by independent laboratories against the Methicillin-resistant bacteria Staphylococcus Aureus (MRSA) and Escherichia Coli (E-Coli), and the feline coronavirus viruses (FCoV) and human coronavirus (SARS-CoV-2).
Therefore, Derprosa Gloss Antimicrobial and Derprosa Matte Antimicrobial are recommended options to ensure the print integrity, provide a glossy or matte finish, and especially—protect those who come in contact with editorial, packaging, or commercial communication pieces in paper support.
These films provide the same properties, machinability, and technical performance as other traditional films including wet, thermal, and thermal digital lamination versions. The antimicrobial effect is long-lasting, odourless, harmless to humans, and totally safe.